West Pharmaceutical Services, Inc. · WST · Next earnings

West Pharmaceutical Services, Inc. reports Thursday, Feb 11, 2027

WST reports before market open with consensus EPS at $2.27 and revenue at $825.2M. Last quarter: WST raises 2026 guidance as HVP demand drives Q3 growth

Reports Before market open98 days awayDate estimated Healthcare

What the street expects

Consensus for the coming report
Consensus EPS $2.27 Calendar consensus
Consensus revenue $825.2M Calendar consensus
Report date Feb 11, 2027 Thursday, date estimated
Session Before market open 98 days away

Where WST left off: FY2026 Q3

Full report

WST raises 2026 guidance as HVP demand drives Q3 growth

EPS surprise +20.9% Reported $2.66 vs $2.20
Revenue surprise +5.7% Reported $874.5M vs $827.1M
Stock move +3.2% Event window
Subsequent drift 0.0% Up to 20 sessions

Management raised full-year 2026 guidance to $3.41-$3.42 billion of revenue and $9.38-$9.48 of EPS, with expected margin expansion.

What to watch on the call

Carried forward from the last transcript

Risks management flagged

  • Foreign-exchange volatility could offset price gains.
  • The SmartDose 3.5 divestiture will weigh on reported growth.
  • Higher inventory and accounts receivable could affect cash flow.
  • Residual cyber-incident effects may continue to affect West Vantage revenue.
  • Regulatory upgrades could increase compliance costs.

Questions analysts left open

  • Whether margin expansion can continue against future gross-margin targets.
  • Whether 10% organic GLP-1 growth assumptions hold, including the effect of generics.
  • Future CapEx intensity and returns on new HVP capacity.

Ask FN2 about WST next report

Choose a question to continue your research
What should I watch for in WST's next earnings report?How did WST guide last quarter, and is consensus above or below that?Give me the bull and bear case going into WST earnings.

Free to start. Your question opens in chat for you to review and send. FN2 can look up the transcript, financials and prior quarters.

Get the WST recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Recent WST quarters

All WST earnings
+3.2%FY2026 Q3-0.8%FY2026 Q2+12.9%FY2026 Q1-1.0%FY2025 Q4

Sources

  1. FN2 corporate events calendar, resolved from the earnings calendar feed
  2. FN2 earnings calendar analyst consensus
  3. Earnings call transcript analysis, FY2026 Q3

Methodology

The report date comes from FN2's resolved corporate-events calendar and is marked estimated until the company confirms it. Consensus figures are the calendar's latest analyst estimates for the fiscal period and are not an FN2 forecast.

Risks and open questions are carried forward verbatim from FN2's structured analysis of the previous earnings call. Missing values stay missing and are never estimated.

By FN2 Research · Updated . For educational purposes only; not investment advice.